切换至 "中华医学电子期刊资源库"

中华肝脏外科手术学电子杂志 ›› 2021, Vol. 10 ›› Issue (06) : 559 -563. doi: 10.3877/cma.j.issn.2095-3232.2021.06.006

临床研究

联合全尾状叶与联合部分尾状叶切除的肝门部胆管癌根治术疗效比较
陈流华1, 黄锡泰1, 刘韩笑1, 赖佳明1, 梁力建1, 殷晓煜1,()   
  1. 1. 510080 广州,中山大学附属第一医院胆胰外科
  • 收稿日期:2021-07-16 出版日期:2021-09-23
  • 通信作者: 殷晓煜
  • 基金资助:
    广东省自然科学基金面上项目(2019A1515010686)

Efficacy comparison between combining total caudate lobotomy and combining partial caudate lobotomy of hilar cholangiocarcinoma radical resection

Liuhua Chen1, Xitai Huang1, Hanxiao Liu1, Jiaming Lai1, Lijian Liang1, Xiaoyu Yin1,()   

  1. 1. Department of Biliary and Pancreatic Surgery, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China
  • Received:2021-07-16 Published:2021-09-23
  • Corresponding author: Xiaoyu Yin
引用本文:

陈流华, 黄锡泰, 刘韩笑, 赖佳明, 梁力建, 殷晓煜. 联合全尾状叶与联合部分尾状叶切除的肝门部胆管癌根治术疗效比较[J/OL]. 中华肝脏外科手术学电子杂志, 2021, 10(06): 559-563.

Liuhua Chen, Xitai Huang, Hanxiao Liu, Jiaming Lai, Lijian Liang, Xiaoyu Yin. Efficacy comparison between combining total caudate lobotomy and combining partial caudate lobotomy of hilar cholangiocarcinoma radical resection[J/OL]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2021, 10(06): 559-563.

目的

比较联合全尾状叶切除与联合部分尾状叶切除的肝门部胆管癌根治术的安全性及远期疗效。

方法

回顾性分析2014年7月至2018年4月中山大学附属第一医院行联合尾状叶切除的33例肝门部胆管癌根治术患者临床资料。患者均签署知情同意书,符合医学伦理学规定。其中男23例,女10例;年龄29~77岁,中位年龄60岁。采用倾向得分匹配法(PSM)将患者以1∶1分为全尾状叶切除组及部分尾状叶切除组,比较两组患者的近期及远期疗效。两组并发症发生率比较采用Fisher确切概率法,手术时间比较采用Mann-Whitney U检验。生存分析采用Kaplan-Meier法和Log-rank检验。

结果

PSM后全尾状叶切除与部分尾状叶切除组各13例。全尾状叶切除组手术时间中位数为390(170)min,明显长于部分尾状叶切除组的300(63)min(Z=2.722,P<0.05)。全尾状叶切除组术后发生并发症8例,部分尾状叶切除组3例,差异无统计学意义(P=0.111)。全尾状叶切除组1、3、5年总体生存率分别为83.1%、44.3%、44.3%,部分尾状叶切除组相应为67.7%、25.4%、25.4%,差异无统计学意义(χ2=0.986,P>0.05)。全尾状叶切除组1、3、5年无复发生存率分别为63.6%、27.3%、27.3%,部分尾状叶切除组相应为57.7%、28.8%、14.4%,差异亦无统计学意义(χ2=0.004,P>0.05)。

结论

在肝门部胆管癌根治术中,与联合部分尾状叶切除相比,全尾状叶切除增加手术时间,但两者术后并发症发生率及长期生存并无明显差异。

Objective

To compare the safety and long-term efficacy between combining total caudate lobotomy and combining partial caudate lobotomy of hilar cholangiocarcinoma radical resection.

Methods

Clinical data of 33 patients with hilar cholangiocarcinoma who underwent radical resection of hilar cholangiocarcinoma combined with caudate lobotomy in the First Affiliated Hospital of Sun Yat-sen University from July 2014 to April 2018 were retrospectively analyzed. The informed consents of all patients were obtained and the local ethical committee approval was received. Among them, 23 patients were male and 10 female, aged from 29 to 77 years, with a median age of 60 years. All patients were divided into the total and partial caudate lobotomy groups with a ratio of 1∶1 by propensity score matching (PSM). The short- and long-term clinical efficacy was statistically compared between two groups. The incidence of complications between two groups was compared by Fisher's exact probability test. The operation time was compared by Mann-Whitney U test. Survival analysis was conducted by Kaplan-Meier method and Log-rank test.

Results

After PSM, 13 patients were assigned into the total caudate lobotomy group and 13 cases into the partial caudate lobotomy group. In the total caudate lobotomy group, the median operation time was 390(170) min, significantly longer than 300(63) min in the partial caudate lobotomy group (Z=2.722, P<0.05). In the total caudate lobotomy group, 8 patients developed postoperative complications and 3 cases in the partial caudate lobotomy group, and no statistical significance was noted between two groups (P=0.111). In the total caudate lobotomy group, the 1-, 3-, 5-year overall survival rates were 83.1%, 44.3%, 44.3%, and 67.7%, 25.4%, 25.4% correspondingly in the partial caudate lobotomy group, and no statistical significance was observed between two groups (χ2=0.986, P>0.05). In the total caudate lobotomy group, the 1-, 3-, 5-year recurrence-free survival rates were 63.6%, 27.3%, 27.3%, and 57.7%, 28.8%, 14.4% in the partial caudate lobotomy group, and no statistical significance was found between two groups (χ2=0.004, P>0.05).

Conclusions

Compared with combining partial caudate lobotomy, combining total caudate lobotomy will prolong the operation time in radical resection of hilar cholangiocarcinoma. Nevertheless, the incidence of postoperative complications and long-term survival do not significantly differ between two operations.

表1 全尾状叶切除组和部分尾状叶切除组肝门部胆管癌患者一般资料PSM前后对比(例)
表2 全尾状叶切除组和部分尾状叶切除组肝门部胆管癌患者PSM后术中和术后情况比较[MQR)]
图1 PSM后全尾状叶切除组与部分尾状叶切除组肝门部胆管癌患者Kaplan-Meier生存曲线注:PSM为倾向得分匹配法
[1]
Poruk KE, Pawlik TM, Weiss MJ. Perioperative management of hilar cholangiocarcinoma[J]. J Gastrointest Surg, 2015, 19(10):1889-1899.
[2]
Kang MJ, Jang JY, Chang J, et al. Actual long-term survival outcome of 403 consecutive patients with hilar cholangiocarcinoma[J]. World J Surg, 2016, 40(10):2451-2459.
[3]
董家鸿,项灿宏,石军, 等. 以围肝门切除为本的肝门部胆管癌治愈性切除术的临床疗效[J]. 中华消化外科杂志, 2017, 16(10): 1053-1060.
[4]
Mansour JC, Aloia TA, Crane CH, et al. Hilar cholangiocarcinoma: expert consensus statement[J]. HPB, 2015, 17(8):691-699.
[5]
Bhutiani N, Scoggins CR, Mcmasters KM, et al. The impact of caudate lobe resection on margin status and outcomes in patients with hilar cholangiocarcinoma: a multi-institutional analysis from the US Extrahepatic Biliary Malignancy Consortium[J]. Surgery, 2018, 163(4):726-731.
[6]
Baek S, Park SH, Won E, et al. Propensity score matching:a conceptual review for radiology researchers[J]. Korean J Radiol, 2015, 16(2):286-296.
[7]
殷晓煜. 肝门部胆管癌手术治疗的热点与难点[J/CD]. 中华肝脏外科手术学电子杂志, 2017, 6(2):81-84.
[8]
殷晓煜. 肝门部胆管癌术前行胆道引流术减轻黄疸的争议与策略[J]. 中华消化外科杂志, 2018, 17(3):229-232.
[9]
毛谅,陈骏,孙士全, 等. 美国癌症联合委员会肝门部胆管癌分期系统(第8版)更新解读[J]. 中国实用外科杂志, 2017, 37(5): 510-513.
[10]
Dinant S, Gerhards MF, Busch OR, et al. The importance of complete excision of the caudate lobe in resection of hilar cholangiocarcinoma[J]. HPB, 2005, 7(4):263-267.
[11]
Birgin E, Rasbach E, Reissfelder C, et al. A systematic review and meta-analysis of caudate lobectomy for treatment of hilar cholangiocarcinoma[J]. Eur J Surg Oncol, 2020, 46(5):747-753.
[12]
Lu J, Li B, Li FY, et al. Long-term outcome and prognostic factors of intrahepatic cholangiocarcinoma involving the hepatic hilus versus hilar cholangiocarcinoma after curative-intent resection: should they be recognized as perihilar cholangiocarcinoma or differentiated?[J]. Eur J Surg Oncol, 2019, 45(11):2173-2179.
[13]
Kimura N, Young AL, Toyoki Y, et al. Radical operation for hilar cholangiocarcinoma in comparable Eastern and Western centers: outcome analysis and prognostic factors[J]. Surgery, 2017, 162(3): 500-514.
[14]
殷晓煜,刘鑫,陈伟, 等. 肝门部胆管癌手术切除的远期疗效及预后因素分析[J]. 中华消化外科杂志, 2016, 15(4):329-333.
[15]
Nimura Y, Hayakawa N, Kamiya J, et al. Hepatic segmentectomy with caudate lobe resection for bile duct carcinoma of the hepatic hilus[J]. World J Surg, 1990, 14(4):535-543.
[16]
Suzuki M, Takahashi T, Ouchi K, et al. The development and extension of hepatohilar bile duct carcinoma. a three-dimensional tumor mapping in the intrahepatic biliary tree visualized with the aid of a graphics computer system[J]. Cancer, 1989, 64(3):658-666.
[17]
Seyama Y, Kubota K, Sano K, et al. Long-term outcome of extended hemihepatectomy for hilar bile duct cancer with no mortality and high survival rate[J]. Ann Surg, 2003, 238(1):73-83.
[18]
Neuhaus P, Jonas S, Settmacher U, et al. Surgical management of proximal bile duct cancer: extended right lobe resection increases resectability and radicality[J]. Langenbecks Arch Surg, 2003, 388(3): 194-200.
[19]
姜小清,程庆保,易滨, 等. 联合计划性肝切除治疗肝门部胆管癌的理论与实践[J]. 中国普外基础与临床杂志, 2016, 23(11): 1289-1292.
[20]
Dumitrascu T, Chirita D, Ionescu M, et al. Resection for hilar cholangiocarcinoma: analysis of prognostic factors and the impact of systemic inflammation on long-term outcome[J]. J Gastrointest Surg, 2013, 17(5):913-924.
[21]
Lim JH, Choi GH, Choi SH, et al. Liver resection for Bismuthtype Ⅰ and type Ⅱ hilar cholangiocarcinoma[J]. World J Surg, 2013, 37(4):829-837.
[22]
Li H. Be cautious in caudate lobectomy for patients with solitary caudate lobe hepatocellular carcinoma and severe cirrhosis[J]. Surgery, 2012, 151(6):901.
[23]
Bogner A, Reissfelder C, Striebel F, et al. Intraoperative increase of portal venous pressure is an immediate predictor of posthepatectomy liver failure after major hepatectomy: a prospective study[J]. Ann Surg, 2021, 274(1):e10-17.
[24]
Rahbari NN, Garden OJ, Padbury R, et al. Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS)[J]. Surgery, 2011, 149(5):713-724.
[25]
Benkö T, Sgourakis G, Molmenti EP, et al. Portal supply and venous drainage of the caudate lobe in the healthy human liver: virtual three-dimensional computed tomography volume study[J]. World J Surg, 2017, 41(3):817-824.
[26]
陈泰安,熊永福,杨发才, 等. 肝门部胆管癌外科治疗进展和争议[J/OL].中华肝脏外科手术学电子杂志, 2021, 10(2):133-138.
[1] 钟锴, 蒋铁民, 张瑞青, 吐尔干艾力·阿吉, 邵英梅, 郭强. 加速康复外科在肝囊型棘球蚴病肝切除术中的应用分析[J/OL]. 中华普通外科学文献(电子版), 2024, 18(06): 425-429.
[2] 朴成林, 蓝炘, 司振铎, 李强, 冯健, 安峰铎, 冷建军. 胰十二指肠切除联合肝切除术疗效分析:附5例报告(附视频)[J/OL]. 中华普通外科学文献(电子版), 2024, 18(05): 363-367.
[3] 冷建军, 朴成林, 司振铎. 胰十二指肠切除术联合小范围肝切除、血管切除重建[J/OL]. 中华普通外科学文献(电子版), 2024, 18(05): 384-384.
[4] 李华志, 曹广, 刘殿刚, 张雅静. 不同入路下行肝切除术治疗原发性肝细胞癌的临床对比[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 52-55.
[5] 冯旺, 马振中, 汤林花. CT扫描三维重建在肝内胆管细胞癌腹腔镜肝切除术中的临床研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 104-107.
[6] 赖全友, 高远, 汪建林, 屈士斌, 魏丹, 彭伟. 三维重建技术结合腹腔镜精准肝切除术对肝癌患者术后CD4+、CD8+及免疫球蛋白水平的影响[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 651-654.
[7] 唐梅, 周丽, 牛岑月, 周小童, 王倩. ICG荧光导航的腹腔镜肝切除术临床意义[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 655-658.
[8] 郭兵, 王万里, 何凯, 黄汉生. 腹腔镜下肝门部胆管癌根治术[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(01): 143-143.
[9] 魏丽霞, 张安澜, 周宝勇, 李明. 腹腔镜下Ⅲb型肝门部胆管癌根治术[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(01): 145-145.
[10] 马振威, 宋润夫, 王兵. ERCP胆道内支架与骑跨十二指肠乳头支架置入治疗不可切除肝门部胆管癌疗效的Meta分析[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 807-812.
[11] 杭轶, 杨小勇, 李文美, 薛磊. 可控性低中心静脉压技术在肝切除术中应用的最适中心静脉压[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 813-817.
[12] 焦振东, 惠鹏, 金上博. 三维可视化结合ICG显像技术在腹腔镜肝切除术治疗复发性肝癌中的应用[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 859-864.
[13] 张润锦, 阳盼, 林燕斯, 刘尊龙, 刘建平, 金小岩. EB病毒相关胆管癌伴多发转移一例及国内文献复习[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 865-869.
[14] 吴警, 吐尔洪江·吐逊, 温浩. 肝切除术前肝功能评估新进展[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 889-893.
[15] 吴雪云, 胡小军, 范应方. 肝切除术中剩余肝再生能力的评估与预测[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 894-897.
阅读次数
全文


摘要